RSV, and influenza leading to increased hospitalizations. The CDC notes a rise in illness across 40 states and predicts ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

Reports of a new respiratory virus in China, known as HMPV (Human Metapneumovirus), have sparked anxiety and humor on social media, evoking memories of the early days of COVID-19 nearly five years ago ...

Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

2. HMPV spreads through close contact with infected individuals or contaminated surfaces. Its symptoms are similar to flu or ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...

Respiratory illnesses are on the rise, but there are ways to prevent the spread. Rhode Island's Department of Health has ...

The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...

COVID-19 activity is increasing in most regions, with test positivity rising to 7.1%. Emergency department visits are also on the rise from previously low levels. The CDC anticipates continued ...

Alabama is one of six states in the U.S. with the highest level of influenza-like cases, according to CDC data.

Thurston County has recorded its first influenza-related death for the 2024-2025 flu season, according to a Friday news ...

Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED ...